Unjha Formulations Intrinsic Value
Unjha Formulations (UNJHAFOR) median intrinsic value is ₹25.12 from 8 valuation models (range ₹16–₹37), vs current price ₹18.55 — +35.4% upside (Trading Below Calculated Value), margin of safety 26.2%. For current market price and key ratios, visit UNJHAFOR share price.
UNJHAFOR Valuation Methods Summary — DCF, Graham Number & P/E
Unjha Formulations intrinsic value across 8 models vs current price ₹18.55 — upside/downside and value range per method. Read UNJHAFOR dividend growth for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹34.54 | ₹27.63 - ₹41.45 | +86.2% | EPS: ₹1.57, Sector P/E: 22x |
| Book Value Method | asset | ₹16.00 | ₹14.40 - ₹17.60 | -13.7% | Book Value/Share: ₹8.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹37.10 | ₹33.39 - ₹40.81 | +100.0% | Revenue/Share: ₹32.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹20.00 | ₹18.00 - ₹22.00 | +7.8% | EBITDA: ₹1.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹25.12 | ₹22.61 - ₹27.63 | +35.4% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹23.95 | ₹21.55 - ₹26.35 | +29.1% | Revenue Growth: 3.4%, Adj P/E: 15.3x |
| ROE Based Valuation | profitability | ₹32.00 | ₹28.80 - ₹35.20 | +72.5% | ROE: 25.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹16.00 | ₹14.40 - ₹17.60 | -13.7% | EPS: ₹1.57, BVPS: ₹8.00 |
UNJHAFOR Intrinsic Value vs Market Price — All Valuation Models
Unjha Formulations fair value range ₹16–₹37 vs current market price ₹18.55 across 8 valuation models. Analyse UNJHAFOR shareholder distribution to track promoter, FII and institutional holdings.
UNJHAFOR Intrinsic Value Analysis — Undervalued or Overvalued?
Unjha Formulations median intrinsic value ₹25.12, current price ₹18.55 — Trading Below Calculated Value by 35.4%, margin of safety 26.2%.
What is the intrinsic value of UNJHAFOR?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Unjha Formulations (UNJHAFOR) is ₹25.12 (median value). With the current market price of ₹18.55, this represents a +35.4% variance from our estimated fair value.
The valuation range spans from ₹16.00 to ₹37.10, indicating ₹16.00 - ₹37.10.
Is UNJHAFOR undervalued or overvalued?
Based on our multi-method analysis, Unjha Formulations (UNJHAFOR) appears to be trading below calculated value by approximately 35.4%.
UNJHAFOR Financial Health — Key Ratios vs Industry Benchmarks
Unjha Formulations financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 25.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.67x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
UNJHAFOR Cash Flow Quality — Operating & Free Cash Flow
Unjha Formulations operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |